| Literature DB >> 24877071 |
Julio A Guerra1, Yesenia C Romero-Herazo1, Octavio Arzuza2, Oscar G Gómez-Duarte1.
Abstract
Enterotoxigenic Escherichia coli (ETEC) are major causes of childhood diarrhea in low and middle income countries including Colombia, South America. To understand the diversity of ETEC strains in the region, clinical isolates obtained from northern Colombia children were evaluated for multiple locus sequencing typing, serotyping, classical and nonclassical virulence genes, and antibiotic susceptibility. Among 40 ETEC clinical isolates evaluated, 21 (52.5%) were positive for LT gene, 13 (32.5%) for ST gene, and 6 (15%) for both ST and LT. The most prevalent colonization surface antigens (CS) were CS21 and CFA/I identified in 21 (50%) and 13 (32.5%) isolates, respectively. The eatA, irp2, and fyuA were the most common nonclassical virulence genes present in more than 60% of the isolates. Ampicillin resistance (80% of the strains) was the most frequent phenotype among ETEC strains followed by trimethoprim-sulfamethoxazole resistance (52.5%). Based on multiple locus sequencing typing (MLST), we recognize that 6 clonal groups of ETEC clinical isolates circulate in Colombia. ETEC clinical isolates from children in northern Colombia are highly diverse, yet some isolates circulating in the community belong to well-defined clonal groups that share a unique set of virulence factors, serotypes, and MLST sequence types.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24877071 PMCID: PMC4022111 DOI: 10.1155/2014/236260
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
ETEC and non-ETEC reference strains used as controls in PCR assays.
| Type | Strain | Serotype | Toxin type | CS type | Source |
|---|---|---|---|---|---|
| ETEC | E24377A | O139:H28 |
|
| Levine et al., 1984 [ |
| ETEC | 910980-2 |
|
|
| NMRCb |
| ETEC | W6520A |
|
|
| NMRC |
| ETEC | WS6866B-2 |
|
|
| NMRC |
| ETEC | M421C1 |
|
|
| VUc |
| ETEC | WS6474D |
|
|
| NMRC |
| ETEC | 911205 |
|
|
| NMRC |
| ETEC | E7476A |
|
|
| NMRC |
| ETEC | 8786 |
|
|
| NMRC |
| ETEC | WS6788A |
|
|
| NMRC |
| ETEC | ARG-2 |
|
|
| NMRC |
| ETEC | DS26-1 | O8:H9 | LT | CS19 | NMRC |
| ETEC | WS7179A-2 | O17:H45 | LTST | CS20 | NMRC |
| ETEC | H10407a | O78:H11 | LT/STh-STp | CFA/I | Evans et al., 1975 [ |
| ETEC | 145C2 | NK | LT/STh | CS2, CS3, CS21 | VU |
| ETEC | E9034A | NK | LT/STh | CS3/CS21 | Levine et al., 1984 [ |
|
| DH5 | None | None | VU |
aStrain used as a positive control for nonclassical virulence factors.
bNMRC refers to Naval Medical Research Center.
cVU refers to Gomez-Duarte's laboratory collection at Vanderbilt University.
NK refers to not known.
Distribution of LT and ST enterotoxins and colonization surface antigens among Colombian ETEC clinical isolates.
| Toxin gene type | Total number of isolatesa | CF type (s) produced | Number (%) of isolates |
|---|---|---|---|
| LT | 21 | CS21 + CFA/I | 1 (4.7) |
| CS21 + CS6 | 3 (14.2) | ||
| CS21 + CS12 | 1 (4.7) | ||
| CS21 + CS7 | 1 (4.7) | ||
| CS21 + CS2 + CS3 | 1 (4.7) | ||
| CS1 | 1 (4.7) | ||
| CS7 | 1 (4.7) | ||
| CS19 | 2 (9.5) | ||
| CS6 | 1 (4.7) | ||
| CF undetectedb | 9 (42.8) | ||
|
| |||
| LT-ST | 6 | CS21 | 1 (16.6) |
| CS5 + CS6 | 4 (66.6) | ||
| CS5 | 1 (16.6) | ||
|
| |||
| ST | 13 | CS21 + CFA/I | 12 (92.3) |
| CF undetectedb | 1 (8.3) | ||
aETEC isolates positive for any enterotoxin and positive or negative for any CSs.
bCSs undetected by PCR reaction.
Figure 1Proportion of nonclassical virulence factor genes among Colombian ETEC clinical isolates. Detection of nonclassical virulence factors was performed by nonvirulence genes PCR amplification of genomic DNA from Colombian ETEC clinical isolates as described in materials and methods.
Figure 2MLST phylogenetic tree and serotyping analyses of Colombian ETEC clinical isolates. Phylogenetic tree constructed after assembly and alignment of MLST DNA sequences using the ClustalW program. MLST and serotyping experiments are described in Materials and Method. E. coli strains from ancestral groups A, B1, B2, and D were used as control for phylogenetic analyses. EAEC: enteroaggregative E. coli; EPEC: enteropathogenic E. coli; ETEC: enterotoxigenic E. coli; STEC: shiga toxin-producing E. coli. (−) refers to negative reaction with standard antisera and/or PCR amplification. (+) refers to positive reaction; the group is novel and does not match known reference standards. (M) Multiple positives. (X) Unclassified O types. (ND) Not done. Numbers 1 to 6 correspond to clonal groups based on identical MLST DNA sequences.
Distribution of MLST sequence types among Colombian ETEC isolates.
| Origin of ETEC isolates number (%) | SeqT | Associated pathotypea | ||
|---|---|---|---|---|
| Child with diarrhea | Healthy child | Total | ||
| 6 | 1 | 7 (17.5) | SeqT2332 | ETEC |
| 1 | 0 | 1 (2.5) | SeqT849 | ETEC |
| 2 | 0 | 2 (5.0) | SeqT88 | ETEC |
| 1 | 0 | 1 (2.5) | SeqT100 | ETEC |
| 0 | 1 | 1 (2.5) | SeqT4 | ETEC |
| 0 | 1 | 1 (2.5) | SeqT94 | ETEC |
| 2 | 0 | 2 (5.0) | SeqT1312 | ETEC |
| 1 | 0 | 1 (2.5) | SeqT731 | ETEC |
| 1 | 1 | 2 (5.0) | SeqT10 | ETEC, EAEC, EPEC, ExPEC |
| 1 | 0 | 1 (2.5) | SeqT34 | EAEC |
| 2 | 0 | 2 (5.0) | SeqT38 | EAEC |
| 1 | 0 | 1 (2.5) | SeqT501 | EAEC |
| 0 | 1 | 1 (2.5) | SeqT23 | EHEC |
| 1 | 0 | 1 (2.5) | SeqT2066 | Commensal |
| 1 | 0 | 1 (2.5) | SeqT216 | Commensal |
| 1 | 0 | 1 (2.5) | SeqT3855 | ETEC |
| 2 | 0 | 2 (5.0) | SeqT641 | Unknown |
| 2 | 0 | 2 (5.0) | SeqT173 | Unknown |
| 1b | 0 | 1 (2.5) | SeqT155 | ETEC, EAEC, ExPEC |
| 4c | 0 | 4 (10.0) | SeqT443 | Unknown |
| 0 | 1d | 1 (2.5) | SeqT1623 | Unknown |
| 1e | 0 | 1 (2.5) | SeqT2067 | Unknown |
| 1 | 0 | 1 (2.5) | SeqT4238f | New SeqT |
| 1 | 0 | 1 (2.5) | SeqT4239f | New SeqT |
| 1 | 0 | 1 (2.5) | SeqT4252g | New SeqT |
|
| ||||
| 34 (85.0) | 6 (15.0) | 40 (100.0) | ||
aAssociated pathotype according to MLST Databases at the ERI, University College Cork. bSingle mutation in fumC at position 158. cSingle mutation in icd at position 158. dSingle mutation in purA at position 260. eMutations in icd at position 110 and fumC at position 153. fNew sequence types submitted to the MLST Databases at the ERI, University College Cork. gNew SeqT submitted to MLST database; in addition, the new icd sequence for this strain was assigned number icd 454.
Level of antibiotic resistance among Colombian ETEC clinical isolates.
| Antibiotics | ETEC isolates number (%) | ||
|---|---|---|---|
| Susceptible | Intermediate | Resistant | |
| Cefazolin (CZ) | 29 (72.5) | 5 (12.5) | 6 (15.0) |
| Ceftriaxone (CRO) | 40 (100) | 0 (0) | 0 (0) |
| Ampicillin (AM) | 8 (20.0) | 5 (15.0) | 27 (67.5) |
| Amoxicillin/clavulanic acid (AMC) | 25 (62.5) | 13 (32.5) | 2 (5.0) |
| Ceftazidime (CAZ) | 40 (100) | 0 (0) | 0 (0) |
| Cefuroxime (CXM) | 39 (97.5) | 1 (2.5) | 0 (0) |
| Cefepime (FEP) | 40 (100) | 0 (0) | 0 (0) |
| Ciprofloxacin (CIP) | 40 (100) | 0 (0) | 0 (0) |
| Gentamicin (GM) | 39 (97.5) | 0 (0) | 1 (2.5) |
| Meropenem (MEM) | 39 (97.5) | 0 (0) | 1 (2.5) |
| Sulfamethoxazole (STX) | 17 (42.5) | 1 (2.5) | 22 (55.0) |
| Piperacillin/tazobactam (TZP) | 40 (100) | 0 (0) | 0 (0) |
Four ETECs resistant to a single antibiotic (AM); 15 resistant to 2 antibiotics (AM and STX), 7 ETEC resistant to 3 antibiotics (AM-STX-CZ or AM-STX-GM or AM-STX-AMC), and a single ETEC resistant to 4 antibiotics (AM, STC, CZ, and AMC).
Characterization of the 6 ETEC clonal groups based on MLST, serotype, classical and nonclassical virulence factors, and antibiotic pattern.
| Isolate | Classical virulence factorsa | Non-classical virulence factors | Clonal groupe | SeqT groupf | Serotype | Antibiotic resistanceh | ||
|---|---|---|---|---|---|---|---|---|
| Enterotoxins | CSc | |||||||
| STb | LT | |||||||
| COCt122 | + | − | CFA/I, CS21 |
| 1 | 2332 | O128:H45 | AM, STX |
| COCt129 | + | − | CFA/I, CS21 |
| 1 | 2332 | O128:H45 | AM, STX |
| COCt142 | + | − | CFA/I, CS21 |
| 1 | 2332 | O128:H45 | AM, STX |
| COCt249 | + | − | CFA/I, CS21 |
| 1 | 2332 | O128:H45 | AM, STX |
| COCt253 | + | − | CFA/I, CS21 |
| 1 | 2332 | O128:H45 | AM, STX |
| COCt310 | + | − | CFA/I, CS21 |
| 1 | 2332 | O128:H45 | AM, STX, CZ |
| COCt140cc | + | − | CFA/I, CS21 |
| 1 | 2332 | O128:H45 | AM, STX, AMC |
|
| ||||||||
| COCt124 | + | + | CS5, CS6 |
| 2 | 443g | O167:H5 | ND |
| COCt201 | + | + | CS5, CS6 |
| 2 | 443g | O167:H5 | AM, STX |
| COCt235 | + | + | CS5, CS6 |
| 2 | 443g | O167:H5 | AM, STX |
| 1COSc36 | + | + | CS5, CS6 |
| 2 | 443g | O167:H5 | AM, STX |
|
| ||||||||
| COCt 161 | + | − | NDd |
| 3 | 38 | O153:H18 | AM, STX, CZ |
| COCt 285 | + | − | CFA/I, CS21 |
| 3 | 38 | O153:H18 | AM, STX |
|
| ||||||||
| 1COCt40 | − | + | CS6, CS21 |
| 4 | 1312 | O25:H16 | AM, STX, CZ |
| 1COSc61 | − | + | CS6, CS21 |
| 4 | 1312 | O25:H16 | AM, STX, CZ |
|
| ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
aST, heat-stable toxin; heat-labile toxin.
bAll ETEC TS positives were positive for the STh variant.
cCS refers to colonization surface antigens.
dND: not detected.
eBased on phylogenetics (see Section 2).
fAs determined by EcMLST (http://mlst.ucc.ie/mlst/dbs/Ecoli).
gETEC strains with SeqT 443 that contain a single icd locus variant. The icd gene has 517/518 matches (mutation in T-229).
hResistance to AM, ampicillin; STX: sulfamethoxazole; CZ: cefazolin; AMC: amoxicillin /clavulanic acid.